Redmile Group’s HOOKIPA Pharma HOOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-106,376
Closed -$214K 60
2024
Q4
$214K Hold
106,376
0.01% 62
2024
Q3
$457K Sell
106,376
-1
-0% -$5 0.03% 63
2024
Q2
$630K Hold
106,377
0.04% 62
2024
Q1
$757K Hold
106,377
0.03% 76
2023
Q4
$862K Hold
106,377
0.03% 66
2023
Q3
$655K Sell
106,377
-222,470
-68% -$1.63M 0.03% 65
2023
Q2
$2.89M Buy
328,847
+73,552
+29% +$817K 0.11% 63
2023
Q1
$1.88M Sell
255,295
-56,182
-18% -$503K 0.08% 66
2022
Q4
$2.52M Sell
311,477
-144,748
-32% -$1.57M 0.1% 60
2022
Q3
$6.11M Hold
456,225
0.24% 57
2022
Q2
$7.44M Sell
456,225
-7,440
-2% -$123K 0.28% 55
2022
Q1
$10.6M Buy
463,665
+225,151
+94% +$4.04M 0.33% 53
2021
Q4
$5.56M Buy
238,514
+54,083
+29% +$2.17M 0.13% 65
2021
Q3
$10.9M Sell
184,431
-1,190
-0.6% -$86.3K 0.19% 63
2021
Q2
$17M Buy
185,621
+1,331
+0.7% +$178K 0.25% 71
2021
Q1
$24.8M Hold
184,290
0.35% 60
2020
Q4
$20.4M Hold
184,290
0.25% 62
2020
Q3
$17.5M Sell
184,290
-1,771
-1% -$181K 0.32% 57
2020
Q2
$21.6M Sell
186,061
-190
-0.1% -$18.5K 0.4% 58
2020
Q1
$15.4M Sell
186,251
-3,001
-2% -$329K 0.43% 49
2019
Q4
$23.1M Sell
189,252
-520
-0.3% -$44.2K 0.55% 47
2019
Q3
$14.2M Buy
189,772
+584
+0.3% +$43.1K 0.48% 47
2019
Q2
$12.7M Buy
+189,188
New +$20.1M 0.36% 54

Other funds holding HOOK

Redmile Group's HOOK Position: Q1 2025 in Review

Redmile Group sold out of HOOKIPA Pharma (HOOK) in Q1 2025, closing a stake of 106,376 shares — an estimated $214K sold.

Redmile Group first reported a position in HOOK in Q2 2019 and held it in 23 quarters. The position peaked at $24.8M in Q1 2021. 32 funds tracked by Wall St. Rank hold HOOK as of Q1 2025.

  • Redmile Group reported no remaining HOOKIPA Pharma position as of Q1 2025 after selling out during the quarter.
  • Redmile Group sold 106,376 HOOKIPA Pharma shares in Q1 2025, an estimated $214K.
  • Redmile Group first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 23 quarters.
  • Redmile Group's HOOKIPA Pharma position peaked at $24.8M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2025.

Based on Redmile Group's 13F filing for Q1 2025, filed 15 May 2025.